Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,484.00
(
-2.04%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.36
(
5.65%
)
Bitcoin
65,992.99
(
-4.06%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

caravon

Send PM Follow Ignore
Followers 12
Posts 1058
Boards Moderated 0
Alias Born 02/21/2007

caravon

Re: DewDiligence post# 211059

Wednesday, 05/03/2017 9:08:57 PM

Wednesday, May 03, 2017 9:08:57 PM

Post# of 257295
The worldwide sale of Viekira ($263 13.1%) vs. Zepatier ($378 18.8%) indicates a gigantic ABBV's HCV marketing failure.

It also indicates, that going forward, GILD's HCV sale leadership status becomes very marginal.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today